KRAS G12C inhibitor 18
This potent, orally bioavailable small molecule selectively inhibits the KRAS G12C mutant protein. It demonstrates robust anti-tumor efficacy in both cellular assays and in vivo xenograft models, making it a valuable tool for oncology research targeting RAS-driven cancers.
Product Specifications
CAS Number
2649788-45-2
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
[H][C@]12CN (CCN1C (=O) c1cc (F) c (c (Cl) c1OCC2) -c1cccc2sc (N) c (C#N) c12) C (=O) C=C
Molecular Formula
C25H20ClFN4O3S
Molecular Weight
510.97
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
